GAYLE PITTS: Open Payments
NPI 1477548956 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 49 payments from 13 companies in 2025. Trend: 2023 $765 · 2024 $740 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $328 |
| Novartis Pharmaceuticals Corporation | 11 | $225 |
| GENZYME CORPORATION | 9 | $181 |
| CSL Behring | 4 | $123 |
| GlaxoSmithKline, LLC. | 6 | $120 |
| Grifols USA, LLC | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Optinose US, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Ionis Pharmaceuticals, Inc. | 1 | $20 |
Products named: AIRSUPRA, DUPIXENT, NUCALA, FASENRA, Rhapsido, Andembry, Hizentra, Xembify.
Industry payments across TN — which companies pay providers there.
